Does USTEKINUMAB Cause Incorrect dose administered? 619 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 619 reports of Incorrect dose administered have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.7% of all adverse event reports for USTEKINUMAB.
619
Reports of Incorrect dose administered with USTEKINUMAB
0.7%
of all USTEKINUMAB reports
3
Deaths
68
Hospitalizations
How Dangerous Is Incorrect dose administered From USTEKINUMAB?
Of the 619 reports, 3 (0.5%) resulted in death, 68 (11.0%) required hospitalization, and 5 (0.8%) were considered life-threatening.
Is Incorrect dose administered Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 619 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Incorrect dose administered?
TIRZEPATIDE (23,301)
ADALIMUMAB (14,000)
DUPILUMAB (9,907)
RANITIDINE (9,337)
INSULIN LISPRO (8,318)
ACETAMINOPHEN (5,316)
DULAGLUTIDE (5,207)
SECUKINUMAB (4,524)
INSULIN GLARGINE (3,070)
SOMATROPIN (2,772)
Which USTEKINUMAB Alternatives Have Lower Incorrect dose administered Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE